Serum cytokines MCP-1 and GCS-F as potential biomarkers in pediatric inflammatory bowel disease.

Andrea OttErol TutdibiSybelle Goedicke-FritzJakob SchöpeMichael ZemlinNasenien Nourkami-Tutdibi

Published in: PloS one (2023)

MCP-1 showed potential as a diagnostic biomarker in CD patients independent of disease activity as it was able to discriminate between subtypes of pediatric IBD. In UC patients, G-CSF was significantly elevated in relapsers indicating its use and role as a potential prognostic biomarker.

Keyphrases

end stage renal disease
disease activity
ejection fraction
newly diagnosed
chronic kidney disease
rheumatoid arthritis
systemic lupus erythematosus
prognostic factors
risk assessment
ankylosing spondylitis
young adults
climate change
nk cells